Objective:To discuss the clinical behavior and treatment of the patients with chest wall bone and soft tissue sarcomas, and to evaluate prognostic factors for the patients. Methods:The clinical data of 46 patients with chest wall and soft tissue sarcomas performed surgical operation between January 2000 and June 2004 in Cancer Hospital of Fudan University were analyzed.Among all the patients,28 patients were treated for the first time,and other 18 patients were treated in other hospital previously and recurred.Eighteen patients were performed thoracectomy,and 9 patients were performed chest wall reconstruction.All the patients were followed up.The average followup period was 26.5 months. Life table method was used for the survival analysis. Results:The 3years diseasefree survival rate was 4843%.The surgical operation time,malignant grade,marginal states and postoperative radiotherapy were prognostic factors for univariate analyses.The primary surgically treated patients had a better prognosis than the recurred patients,and 3years diseasefree survival rates were 73% and 15%,P=00032.The patients with low histologic grade had a better prognosis than with high grade,and 3years diseasefree survival rates were 74% and 28%,P=0.0008.The patients with negative margin had a better prognosis than with positive margin,and 3years diseasefree survival rates were 64% and 13%,P=0.0005.The patients without postoperative radiotherapy had a better prognosis than with postoperative radiotherapy,and 3years diseasefree survival rates were 60% and 33%,P=0.0363.The surgical time,malignant grade,marginal states were independent predicators for the risk of recurrence at multivariate analyses. Conclusion:The diseasefree survival of the chest wall bone and soft tissue sarcomas is related to surgical treatment and tumor malignant grade.The chest wall bone and soft tissue sarcomas could be controlled by proper surgical resection.